<DOC>
	<DOCNO>NCT00684671</DOCNO>
	<brief_summary>Only subject participated primary study invite participate extension phase challenge dose phase study .</brief_summary>
	<brief_title>Evaluation Immune Memory Twinrix Comparator Challenge Dose Administration 4 Years After Primary Vaccination</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects investigator believe comply requirement protocol . A male female complete primary vaccination phase HAB160 study ( NCT 00603252 ) . Written inform consent obtain subject . If subject female , must nonchildbearing potential ; , childbearing potential , must abstinent use adequate contraceptive precaution 30 day prior vaccination , negative pregnancy test must agree continue precaution two month vaccination . The following criterion check time study entry . If apply , subject must include study : Use investigational nonregistered product ( drug vaccine ) study vaccine within 30 day precede challenge dose , plan use study period . History hepatitis A hepatitis B vaccination infection since primary vaccination study . History allergic disease reaction likely exacerbate component vaccine . Acute disease time enrolment . Pregnant lactate female .</criteria>
	<gender>All</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Immune memory</keyword>
	<keyword>Combined hepatitis A B vaccine</keyword>
	<keyword>&gt; 41 year old</keyword>
</DOC>